Are you familiar with Harvard Pilgrim’s Cardiac Medication Adherence report? On a semi-annual basis, Harvard Pilgrim sends a Cardiac Medication Adherence Report to PCPs for each patient discharged with an acute myocardial infarction (AMI), or heart attack, in the past two years. The report identifies patients who may require follow-up due to gaps in their adherence to beta blocker therapy and other cardiac medications.
The importance of beta blocker therapy after an AMI is widely recognized. According to the results of large-scale clinical trials, beta blockers consistently reduce subsequent coronary events, cardiovascular mortality, and all-cause mortality by 20 to 30 percent after an AMI when taken indefinitely. Today, according to published research, more than 90 percent of patients discharged from the hospital after having a heart attack receive beta blockers. Despite the proven long-term benefits of beta blockers, many patients don’t take the medication as prescribed after discharge.
In the Cardiac Medication Adherence Report, Harvard Pilgrim calculates beta blocker Proportion of Days Covered (PDC) — the sum of days' supply for all beta blocker pharmacy claims divided by the number of days elapsed for that time period — for each patient discharged after having a heart attack. Our analysis revealed that from January to June 2016 only 60 percent of Harvard Pilgrim members achieved a PDC rate of 80% or higher to beta blocker therapy 6 months post AMI and for January to June 2017 that number was 70%.
The Cardiac Medication Adherence Report can help PCPs identify such gaps in care. It displays each patient’s: name and date of birth; AMI discharge date; most recent six-month refill history of cardiac medications; the prescribing physician’s name and phone number, and the patient’s beta blocker PDC rate. This report can help PCPs:
- identify patients discharged with a diagnosis of an AMI,
- identify specialist(s) caring for their patient,
- review cardiac medication fill history,
- identify non-adherence or discrepancies with a patient’s cardiac medications including beta blockers,
- coordinate care with a specialist.
For more information about this report, please contact our Clinical Programs Department at 800-287-9793.